Compass has resolved the significant issues with its financial filings, known as material weaknesses, meeting a self-imposed deadline. The disclosure generally refers to a systemic problem at a ...

Compass achieved its free cash flow goal in Q2, but still records a net loss of $46.9 million. During the second quarter of 2023, Compass recorded a free cash flow of $51 million, compared to a free ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.5, with a high ...

LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today ...

Compass ranks No. 106 on the list of 500 fastest-growing companies DALLAS, April 3, 2025 /PRNewswire/ -- Compass Datacenters has been named one of the fastest-growing companies in the Americas by the ...

Phase 3 COMP005 trial in participants with treatment resistant depression (TRD) 6-week top-line data on track for second quarter 2025 Phase 3 COMP006 in TRD is on track for 26-week data in second half ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today ...